BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22264987)

  • 1. Priority symptoms in advanced breast cancer: development and initial validation of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
    Garcia SF; Rosenbloom SK; Beaumont JL; Merkel D; Von Roenn JH; Rao D; Cella D
    Value Health; 2012 Jan; 15(1):183-90. PubMed ID: 22264987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment- and disease-related symptoms in advanced head and neck cancer: validation of the national comprehensive cancer network-functional assessment of cancer therapy-head and neck cancer symptom index-22 (NFHNSI-22).
    Pearman TP; Beaumont JL; Paul D; Abernethy AP; Jacobsen PB; Syrjala KL; Von Roenn J; Cella D
    J Pain Symptom Manage; 2013 Jul; 46(1):113-20. PubMed ID: 23017622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content validity of the National Comprehensive Cancer Network - Functional Assessment of Cancer Therapy - Breast Cancer Symptom Index (NFBSI-16) and Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form with advanced breast cancer patients.
    Krohe M; Tang DH; Klooster B; Revicki D; Galipeau N; Cella D
    Health Qual Life Outcomes; 2019 May; 17(1):92. PubMed ID: 31142325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI).
    Yost KJ; Yount SE; Eton DT; Silberman C; Broughton-Heyes A; Cella D
    Breast Cancer Res Treat; 2005 Apr; 90(3):295-8. PubMed ID: 15830143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement properties of the eight-item abbreviated functional assessment of cancer therapy--breast symptom index and comparison with its 37-item parent measure.
    Lee CF; Ng R; Wong NS; Luo N; Yap YS; Lo SK; Chia WK; Yee A; Krishna L; Wong C; Goh C; Cheung YB
    J Pain Symptom Manage; 2013 Apr; 45(4):782-91. PubMed ID: 22926085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient assessment of the most important symptoms in advanced prostate cancer: the NCCN/FACT-P Symptom Index.
    Victorson DE; Beaumont JL; Rosenbloom SK; Shevrin D; Cella D
    Psychooncology; 2011 Sep; 20(9):977-83. PubMed ID: 20661866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of Paper-Based and Web-Based Versions of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16) Questionnaire in Breast Cancer Patients: Randomized Crossover Study.
    Ma J; Zou Z; Pazo EE; Moutari S; Liu Y; Jin F
    JMIR Med Inform; 2021 Mar; 9(3):e18269. PubMed ID: 33650978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief assessment of priority symptoms in hormone refractory prostate cancer: the FACT Advanced Prostate Symptom Index (FAPSI).
    Yount S; Cella D; Banik D; Ashraf T; Shevrin D
    Health Qual Life Outcomes; 2003 Nov; 1():69. PubMed ID: 14633279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
    So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
    Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the Functional Assessment of Cancer Therapy-General (FACT-G) scale for measuring the health-related quality of life in Korean women with breast cancer.
    Lee EH; Chun M; Kang S; Lee HJ
    Jpn J Clin Oncol; 2004 Jul; 34(7):393-9. PubMed ID: 15342666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized symptom and quality-of-life assessment for patients with cancer part I: development and pilot testing.
    Berry DL; Trigg LJ; Lober WB; Karras BT; Galligan ML; Austin-Seymour M; Martin S
    Oncol Nurs Forum; 2004 Sep; 31(5):E75-83. PubMed ID: 15378104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue.
    Cella D
    Semin Hematol; 1997 Jul; 34(3 Suppl 2):13-9. PubMed ID: 9253779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale.
    Cheng KK; Wong EM; Ling WM; Chan CW; Thompson DR
    J Pain Symptom Manage; 2009 Jan; 37(1):44-57. PubMed ID: 18538976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
    Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
    J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: the RAND 36-Item Health Survey and the Functional Living Index-Cancer.
    Wilson RW; Hutson LM; Vanstry D
    Phys Ther; 2005 Sep; 85(9):851-60. PubMed ID: 16117596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer.
    Stanton AL; Bernaards CA; Ganz PA
    J Natl Cancer Inst; 2005 Mar; 97(6):448-56. PubMed ID: 15770009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptom research in gynecologic oncology: a review of available measurement tools.
    Agarwal S; Bodurka DC
    Gynecol Oncol; 2010 Nov; 119(2):384-9. PubMed ID: 20688364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom concerns and quality of life in hepatobiliary cancers.
    Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
    Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.